(Q42833017)

8 November 2017

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma (English)

1 reference

8 November 2017

1 reference

Reginato MJ

1

1 reference

8 November 2017

Krakow SL

series ordinal

2

1 reference

8 November 2017

Bailey ST

series ordinal

3

1 reference

8 November 2017

Lazar MA

series ordinal

4

1 reference

8 November 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Journal of Biological Chemistry

8 November 2017

1 reference

8 November 2017

273

1 reference

8 November 2017

1855-1858

1 reference

8 November 2017

4

1 reference

Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.

8 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Effect of obesity on ambient plasma glucose, free fatty acid, insulin, growth hormone, and glucagon concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Regulation of GLUT4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Arachidonic acid and eicosanoids as targets and effectors in second messenger interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

The eicosanoids and their biochemical mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

The nuclear receptor superfamily: the second decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Preadipocyte differentiation blocked by prostaglandin stimulation of prostanoid FP2 receptor in murine 3T3-L1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Paracrine regulation of adipose differentiation by arachidonate metabolites: prostaglandin F2 alpha inhibits early and late markers of differentiation in the adipogenic cell line 1246

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Peroxisome proliferators activate extracellular signal-regulated kinases in immortalized mouse liver cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Developmentally regulated mRNAs in 3T3-adipocytes: analysis of transcriptional control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

The PPARalpha-leukotriene B4 pathway to inflammation control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Peroxisome proliferator-activated receptor gamma1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumonocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

The organization, promoter analysis, and expression of the human PPARgamma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Mechanisms modifying glucose oxidation in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.4.1855

21 January 2018

Identifiers

DOI

10.1074/JBC.273.4.1855

1 reference

8 November 2017

1 reference